Choline and PEG dually modified artemether nano delivery system targeting intra-erythrocytic Plasmodium and its pharmacodynamics in vivo

References

• Xing J, Bai KH, Liu T, et al. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats. Xenobiotica. 2011;41(3):252–258.
   PubMed Web of Science ®Google Scholar
• Zhang SQ, Hai TN, Ilett KF, et al. Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers. Br J Clin Pharmacol. 2001;52(4):377–385.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang ZH, Jiang YQ, et al. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent tamibarotene: characterization and evaluation. Drug Deliv. 2015;22(2):223–229.
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm. 2010;394(1–2):179–185.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28–51.
   PubMed Web of Science ®Google Scholar
• Uskokovic V, Lee PP, Walsh LA, et al. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomaterials. 2012;33(5):1663–1672.
   PubMed Web of Science ®Google Scholar
• Chen XX, Zhang YW, Zhao PF, et al. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects. Drug Dev Ind Pharm. 2020;46(1):57–69.
   PubMed Web of Science ®Google Scholar
• Golenser J, Waknine JH, Krugliak M, et al. Current perspectives on the mechanism of action of artemisinins. Int J Parasitol. 2006;36(14):1427–1441.
   PubMed Web of Science ®Google Scholar
• Meshnick SR. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol. 2002;32(13):1655–1660.
   PubMed Web of Science ®Google Scholar
• Goodyer ID, Pouvelle B, Schneider TG, et al. Characterization of macromolecular transport pathways in malaria-infected erythrocytes. Mol Biochem Parasitol. 1997;87(1):13–28.
   PubMed Web of Science ®Google Scholar
• Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev. 2001;81(2):495–537.
   PubMed Web of Science ®Google Scholar
• Wein S, Maynadier M, Bordat Y, et al. Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate. Br J Pharmacol. 2012;166(8):2263–2276.
   PubMed Web of Science ®Google Scholar
• Biagini GA, Ward SA, Bray PG. Malaria parasite transporters as a drug-delivery strategy. Trends Parasitol. 2005;21(7):299–301.
   PubMed Web of Science ®Google Scholar
• Peyrottes S, Caldarelli S, Wein S, et al. Choline analogues in malaria chemotherapy. Curr Pharm Des. 2012;18(24):3454–3466.
   PubMed Web of Science ®Google Scholar
• Safwat S, Ishak RAH, Hathout RM, et al. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Drug Dev Ind Pharm. 2017;43(7):1112–1125.
   PubMed Web of Science ®Google Scholar
• Ren GL, Chen P, Tang JQ, et al. Construction and cellular uptake evaluation of redox-responsive docetaxel prodrug self-assembled nanoparticles. Drug Dev Ind Pharm. 2018;44(4):598–607.
   PubMed Web of Science ®Google Scholar
• Akhter MH, Kumar S, Nomani S. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies. Drug Dev Ind Pharm. 2020;46:1–14.
   PubMed Web of Science ®Google Scholar
• Yang RL, Zhang SA, Kong DL, et al. Biodegradable polymer–curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res. 2012;29(12):3512–3525.
   PubMed Web of Science ®Google Scholar
• Trager W, Jensen JB. Human malaria parasites in continuous culture. 1976. J Parasitol. 2005;91(3):484–486.
   PubMed Web of Science ®Google Scholar
• Waterkeyn JG, Cowman AF, Cooke BM. Plasmodium falciparum: gelatin enrichment selects for parasites with full-length chromosome 2. Implications for cytoadhesion assays. Exp Parasitol. 2001;97(2):115–118.
   PubMed Web of Science ®Google Scholar
• Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65(3):418–420.
   PubMed Web of Science ®Google Scholar
• Saul A, Graves P, Edser L. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol. Int J Parasitol. 1990;20(8):1095–1097.
   PubMed Web of Science ®Google Scholar
• Johnson JD, Dennull RA, Gerena L, et al. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51(6):1926–1933.
   PubMed Web of Science ®Google Scholar
• Dawre S, Pathak S, Sharma S, et al. Enhanced antimalalarial activity of a prolonged release in situ gel of arteether–lumefantrine in a murine model. Eur J Pharm Biopharm. 2018;123:95–107.
   PubMed Web of Science ®Google Scholar
• Zhang GS, Dai HL, Ren GL, et al. Antimalarial activity and metabolism of dihydroartemisinin-derived dimer. Parasitol Res. 2018;117(7):2243–2254.
   PubMed Web of Science ®Google Scholar
• Basco LK, Le Bras J. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 1993;49(3):301–307.
   PubMed Web of Science ®Google Scholar
• Staines HM, Powell T, Thomas SL, et al. Plasmodium falciparum-induced channels. Int J Parasitol. 2004;34(6):665–673.
   PubMed Web of Science ®Google Scholar
• Li Y. Qinghaosu (artemisinin): chemistry and pharmacology. Acta Pharmacol Sin. 2012;33(9):1141–1146.
   PubMed Web of Science ®Google Scholar
• Bhise K, Kashaw SK, Sau S, et al. Nanostructured lipid carriers employing polyphenols as promising anticancer agents: quality by design (QbD) approach. Int J Pharm. 2017;526(1–2):506–515.
   PubMedGoogle Scholar
• Xie SC, Dogovski C, Kenny S, et al. Optimal assay design for determining the in vitro sensitivity of ring stage Plasmodium falciparum to artemisinins. Int J Parasitol. 2014;44(12):893–899.
   PubMed Web of Science ®Google Scholar
• Horrocks P, Pinches RA, Chakravorty SJ, et al. PfEMP1 expression is reduced on the surface of knobless Plasmodium falciparum infected erythrocytes. J Cell Sci. 2005;118(Pt 11):2507–2518.
   PubMed Web of Science ®Google Scholar
• Schuster FL. Cultivation of plasmodium spp. Clin Microbiol Rev. 2002;15(3):355–364.
   PubMed Web of Science ®Google Scholar
• Langreth SG, Peterson E. Pathogenicity, stability, and immunogenicity of a knobless clone of Plasmodium falciparum in Colombian owl monkeys. Infect Immun. 1985;47(3):760–766.
   PubMed Web of Science ®Google Scholar
• Janse CJ, Waters AP, Kos J, et al. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model. Int J Parasitol. 1994;24(4):589–594.
   PubMed Web of Science ®Google Scholar